drugset / Trial / NCT02722421
Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected Women
Phase 2
Completed
28 enrolled
University of Nebraska
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collabInfectious Diseases Institute, Uganda · collabNorthwestern University · collabUniversity of Liverpool · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether increasing the dose of the levonorgestrel subdermal contraceptive implant will overcome a detrimental drug-drug interaction with efavirenz based antiretroviral therapy.
Timeline
- Start
- 2017-04-06
- Primary completion
- 2019-12-05
- Completion
- 2020-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | — | Other |
| Background | Efavirenz | Other / unclassified | — | — |